Challenging scenarios in a travel clinic: Advising the complex traveler

Infectious Disease Clinics of North America

Volumn 19, Issue 1, 2005, Pages 15-47

  Suh, Kathryn N ^a,b   Mileno, Maria D ^c,d  

^a CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

^c MIRIAM HOSPITAL   (United States)

^d BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATOVAQUONE PLUS PROGUANIL; BACTERIAL VACCINE; BCG VACCINE; CHLOROQUINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; DOXYCYCLINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS A ANTIBODY; HEPATITIS A VACCINE; INACTIVATED VACCINE; INFLUENZA VACCINE; JAPANESE ENCEPHALITIS VACCINE; LIVE VACCINE; LOPERAMIDE; MALARIA VACCINE; MEASLES MUMPS RUBELLA VACCINE; MENINGOCOCCUS VACCINE; PERTUSSIS VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; POLYSACCHARIDE VACCINE; RABIES VACCINE; RECOMBINANT HEPATITIS B VACCINE; TETANUS TOXOID; TICK BORNE ENCEPHALITIS VACCINE; TYPHOID VACCINE; UNINDEXED DRUG; VACCINE; VARICELLA ZOSTER VACCINE; YELLOW FEVER VACCINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AGE DISTRIBUTION; BACTERIAL INFECTION; BIOSAFETY; BREAST FEEDING; CONSULTATION; DIABETES MELLITUS; DIPHTHERIA; DOSE RESPONSE; ELDERLY CARE; EPIDEMIC ENCEPHALITIS; EPILEPSY; GASTROINTESTINAL DISEASE; HEALTH STATUS; HEPATITIS A; HEPATITIS B; HERPES ZOSTER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; ILEUS; IMMUNIZATION; INFECTION; INFLUENZA; MALARIA; MARITAL THERAPY; MEASLES; MENINGOCOCCOSIS; MENTAL DISEASE; MUMPS; OUTPATIENT DEPARTMENT; PATIENT COUNSELING; PEDIATRICS; PERTUSSIS; POLIOMYELITIS; PREGNANCY; RABIES; RESPIRATION DEPRESSION; REVIEW; RISK FACTOR; RUBELLA; SEIZURE; SIDE EFFECT; SOUTH AMERICA; STREPTOCOCCUS INFECTION; SURVIVAL; TETANUS; TICK BORNE ENCEPHALITIS; TOXIC MEGACOLON; TRAVEL; TRAVELLER DIARRHEA; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME; TUBERCULOSIS; TYPHOID FEVER; YELLOW FEVER;

EID: 13444311946     PISSN: 08915520     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idc.2004.10.004     Document Type: Review

References (64)

1. Centers for Disease Control and Prevention Inactivated Japanese encephalitis virus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mort Wkly Rep 42 RR-01 1994 1 22
2. Z.A. Memish Meningococcal disease and travel Clin Infect Dis 34 2002 84 90
3. Centers for Disease Control and Prevention Typhoid immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mort Wkly Rep 43 RR-14 1994 1 7
4. E.B. Steinberg, R. Bishop, and P. Haber Typhoid fever in travelers: who should be targeted for prevention? Clin Infect Dis 39 2004 186 191
5. Centers for Disease Control and Prevention Health information for international travel 2003-4 2003 US Department of Health and Human Services, Public Health Service Atlanta, (GA)
6. US Customs and Border Security. www.cbp.gov/xp/cgov/travel. Accessed 5 June 2004.
7. Federal Aviation Agency. www.faa.gov/passengers/childsafetyseats.cfm. Accessed 4 June 2004.
8. S. Ratnam, R. Chandra, and V. Gadag Maternal measles and rubella antibody levels and serologic response in infants immunized with MMR II at 12 months of age J Infect Dis 168 1993 1596 1598
9. C.A. Siegrist Mechanisms by which maternal antibodies influence infant immune responses: review of hypotheses and definition of main determinants Vaccine 21 2003 3406 3412
10. W.M. Stauffer, and D. Kamat Traveling with infants and children. Part II: Immunizations J Travel Med 9 2002 82 90
11. S.M. Mackell Vaccinations for the pediatric traveler Clin Infect Dis 37 2003 1508 1516
12. Centers for Disease Control and Prevention Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2002 MMWR Morb Mort Wkly Rep 51 RR-17 2002 1 11
13. T.P. Monath Yellow fever S.A. Plotkin W. Orenstein Vaccines 3rd edition 1999 WB Saunders Philadelphia 858 863
14. A.E. Fiore, C.N. Shapiro, and K. Sabin Hepatitis A vaccination of infants: effect of maternal antibody status on antibody persistence and response to a booster dose Pediatr Infect Dis J 22 2003 354 359
15. M. van der Wielen, P. van Damme, and F. Collard A two dose schedule for combined hepatitis A and hepatitis B vaccination in children ages one to eleven years Pediatr Infect Dis J 19 2000 848 853
16. A.L. Reingold, C.V. Broome, and A.W. Hightower Age-specific differences in duration of clinical protection after vaccination with meningococcal polysaccharide A vaccine Lancet 326 1985 114 118
17. J.M. MacLennan, F. Shackley, and P.T. Heath Safety, immunogenicity, and induction of immunologic memory by a serogroup C meningococcal conjugate vaccine in infants: a randomized controlled trial JAMA 283 2000 2795 2801
18. P. Balmer, R. Borrow, and E. Miller Impact of meningococcal C conjugate vaccine in the UK J Med Microbiol 51 2002 717 722
19. E.A. Engels, and J. Lau Vaccines for preventing typhoid fever Cochrane Database Syst Rev 2000 CD 001261
20. Centers for Disease Control and Prevention Typhoid immunizations: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Morb Mort Wkly Rep 43 RR-14 1994 1 14
21. J.W. Bell, J.C. Veltri, and B.C. Page Human exposures to N, N-diethyl-m-toluamide insect repellents reported to the American Association of Poison Control Centers 1993-1997 Int J Toxicol 21 2002 341 352
22. W.M. Stauffer, D. Kamat, and A.J. Magill Traveling with infants and children. Part IV: Insect avoidance and malaria prevention J Travel Med 10 2003 225 240
23. C. Luxemberger, R.N. Price, and F. Nosten Mefloquine in infants and young children Ann Trop Paediatr 16 1996 281 286
24. B. Lell, D. Luckner, and M. Ndjave Randomised placebo-controlled study of atovaquone plus proguanil for malaria prophylaxis in children Lancet 351 1998 709 713
25. B. Pitzinger, R. Steffen, and A. Tschopp Incidence and clinical features of traveler's diarrhea in infants and children Pediatr Infect Dis J 10 1991 719 723
26. W.M. Stauffer, R.J. Konop, and D. Kamat Traveling with infants and young children. Part III: travelers' diarrhea J Travel Med 9 2002 141 150
27. T.E. Tupasi Quinolones in the developing world: state of the art Drugs 58 1999 55 59
28. H. Gomi, Z.D. Jiang, and J.A. Adachi In vitro susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions Antimicrob Agents Chemother 45 2001 212 216
29. R. Kuschner, A.F. Trofa, and R.J. Thomas Use of azithromycin for the treatment of Campylobacter enteritis in travelers to Thailand, an area where ciprofloxacin resistance is prevalent Clin Infect Dis 21 1995 536 541
30. R.O. Cummins, and J.A. Schubach Frequency and types of medical emergencies among commercial air travelers JAMA 261 1989 1295 1299
31. A.E. McCarthy Travelers with pre-existing disease J.S. Keystone P.E. Kozarsky D.O. Freedman Travel medicine 2004 Mosby Edinburgh 241 247
32. Centers for Disease Control and Prevention Tetanus surveillance: 1998-2000 MMWR Morb Mort Wkly Rep 52 SS-03 2003 1 8
33. M. Martin, L.H. Weld, and T.F. Tsai Advanced age as a risk factor for illness temporally associated with yellow fever vaccination Emerg Infect Dis 7 2001 945 951
34. J. Bacaner, B. Stauffer, and Boulware Travel medicine considerations for North American immigrants visiting friends and relatives JAMA 291 2004 2856 2864
35. M.D. Mileno, and F.J. Bia The compromised traveler Infect Dis Clin North Am 12 1998 369 412
36. Diabetes Monitor. www.diabetesmonitor.com. Accessed 7 July 2004.
37. T. Sane, V.A. Koivisto, and P. Nikkanen Adjustment of insulin doses of diabetic patients during long distance flights BMJ 301 1990 421 422
38. M.K. Glynn, C.R. Friedman, and B.D. Gold Seroincidence of Helicobacter pylori infection in a cohort of rural Bolivian children: acquisition and analysis of possible risk factors Clin Infect Dis 35 2002 1059 1065
39. R.E. Begue, A. Mirza, and T. Compton Helicobacter pylori infection and insulin requirement among children with type 1 diabetes mellitus Pediatrics 103 1999 e83
40. M. Freeman, A. Ghidini, and C.Y. Spong Does air travel affect pregnancy outcome? Arch Gynecol Obstet 269 2004 274 277
41. American Academy of Pediatrics Immunization in special circumstances L.K. Pickering Red Book: 2003 Report of the Committee on Infectious Diseases 26th edition 2003 American Academy of Pediatrics Elk Grove Village (IL) 66 69
42. B. Vanhauwere, H. Maradit, and L. Kerr Post marketing surveillance of prophylactic mefloquine (LARIAM) use in pregnancy Am J Trop Med Hyg 58 1998 17 21
43. American Academy of Pediatrics Rubella L.K. Pickering Red Book: 2003 Report of the Committee on Infectious Diseases 26th edition 2003 American Academy of Pediatrics Elk Grove Village (IL) 536 541
44. B. Bar-Oz, M. Bulkowstein, and L. Benyamini Use of antibiotic and analgesic drugs during lactation Drug Saf 26 2003 925 935
45. Aidsnet. www.aidsnet.ch/index.php?newlang=english under "Immigration Clauses". Accessed 7 July 2004.
46. F. Castelli, and C. Pizzocolo The traveler with HIV J.S. Keystone P.E. Kozarsky D.O. Freedman Travel medicine 2004 Mosby Edinburgh 257 266
47. U. Thisyakorn, C. Pancharoen, and K. Ruxrungtham Safety and immunogenicity of preexposure rabies vaccination in children infected with human immunodeficiency virus type 1 Clin Infect Dis 30 2000 218
48. P. Thaithumyanon, S. Punnahitananda, and U. Thisyakorn Immune responses to measles immunization and the impacts on HIV-infected children Southeast Asian J Trop Med Public Health 31 2000 658 662
49. P. Tattevin, A.G. Depatureaux, and J.M. Chapplain Yellow fever vaccine is safe and effective in HIV-infected patients AIDS 18 2004 835 837
50. J. Whitworth, D. Morgan, and M. Quigley Effect of HIV-1 and increasing immunosuppression on malaria parasitaemia and clinical episodes in adults in rural Uganda: a cohort study Lancet 356 2000 1051 1056
51. A. Ramos, D.J. Hu, and L. Nguyen Intersubtype human immunodeficiency virus type 1 superinfection following seroconversion to primary infection in two injection drug users J Virol 76 2002 7444 7452
52. Y. Khaliq, K. Gallicano, and C. Tisdale Pharmacokinetic interaction between mefloquine and ritonavir in healthy volunteers Br J Clin Pharmacol 51 2001 591 600
53. E.F. Schippers, P.W. Hugen, and J. den Hartigh No drug-drug interaction between nelfinavir or indinavir and mefloquine in HIV-1-infected patients AIDS 14 2000 2794 2795
54. R. Colebunders, J. Nachega, and A. van Gompel Antiretroviral treatment and travel to developing countries J Travel Med 6 1999 27 31
55. P. Schlagenhauf, C. Beallor, and K.C. Kain Malaria chemoprophylaxis J.S. Keystone P.E. Kozarsky D.O. Freedman Travel medicine 2004 Mosby Edinburgh 137 156
56. D. Tessier Immunocompromised travelers P. Schlagenhauf Travelers' malaria 2004 BC Decker Hamilton, ON 324 335
57. Centers for Disease Control and Prevention Guidelines for preventing opportunistic infections among HIV-infected persons - 2002. Recommendations of the US Public Health Service and the Infectious Diseases Society of America MMWR Morb Mort Wkly Rep 51 RR-8 2002 1 52
58. A.K. Boggild, M. Sano, and A. Humar Travel patterns and risk behavior in solid organ transplant recipients J Travel Med 11 2004 37 43
59. K.V. Rolston, and J.R. Wingard Managing infections in patients with hematologic malignancies 2003 Academy for Heathcare Education New York p. 1-22
60. M. Mileno Preparation of immunocompromised travelers J.S. Keystone P.E. Kozarsky D.O. Freedman Travel medicine 2004 Mosby Edinburgh 249 255
61. D.A.R. Watson Pretravel health advice for asplenic individuals J Travel Med 10 2003 117 121
62. R. Gowda, K. Cartwright, and J.A. Bremmer Yellow fever vaccine: a successful vaccination of an immunocompromised patient Eur J Haematol 72 2004 299 301
63. Committee on Sports Medicine and Fitness Medical conditions affecting sports participation Pediatrics 107 2001 1205 1209
64. A. Richens, and C. Andrews Clinical practice: antimalarial prophylaxis in patients with epilepsy Epilepsy Res 51 2001 1 4